80% of moneycontrol users recommend buying Sun Pharma.
What's your call on Sun Pharma today?
Read 39 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||3200.60||-0.88||3353.85||2420.00||54,527.29|
|Mar' 14||Dec' 13||Sep' 13||Aug' 13|
National Buildings Constr Recommended on Jul 14th 2014
Recommended price 396.00 | Peak from reco 767.50 93.69%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Sun Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 178,213.30 crore.The company has reported a consolidated sales of Rs 4,043.57 crore and a Net Profit of Rs 1,764.49 crore for the quarter ended Mar 2014.
The company management includes Israel Makov - Chairman, Dilip S Shanghvi - Managing Director, Sudhir V Valia - Whole Time Director, Sailesh T Desai - Whole Time Director, S Mohanchand Dadha - Director, Hasmukh S Shah - Director, Keki M Mistry - Director, Ashwin Dani - Director, Rekha Sethi - Addnl.Independent Director.
It is listed on the BSE with a BSE Code of 524715 and the NSE with an NSE Code of SUNPHARMA.
Its Registered office is at Sun Pharma Advanced Research Centre (SP Tandalja,,Akota Road Vadodra,Gujarat - 390020.